BIOMAT Database Logo BIOMAT Database Logo

Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents. 1997

N Poonwan, and Y Mikami, and S Poosuwan, and J Boon-Long, and N Mekha, and M Kusum, and K Yazawa, and R Tanaka, and K Nishimura, and K Konyama
Department of Medical Sciences, National Institute of Health, Nonthaburi, Thailand.

One hundred and thirty-nine strains of Cryptococcus neoformans were isolated in Thailand from clinical specimens including 97 AIDS patients: 67 from Northern, 48 from Central, 17 from Northeastern and 7 from Southern regional hospitals. Six out of the 139 strains were serotype B and the remaining 133 were A. There was no correlation between serotypes and regional distribution. To our knowledge, this is the first report of serotyping studies on C. neoformans in Thailand. Studies on random amplified polymorphic DNA (RAPD) analysis showed that this method is useful for the differentiation of C. neoformans var. gattii (serotypes B and C) and C. neoformans var. neoformans (serotypes A and D). They also indicated that Thai isolates of C. neoformans var. gattii (serotype B) were a homogeneous group on the basis of their genotypes. Antifungal susceptibility tests using 5 antifungal agents including amphotericin B, fluconazole, flucytosine, itraconazole and micronazole against 50 selected strains of C. neoformans showed that they were sensitive to all of the antifungal agents tested except for one strain that was resistant to flucytosine.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002555 Cerebrospinal Fluid A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES. Cerebro Spinal Fluid,Cerebro Spinal Fluids,Cerebrospinal Fluids,Fluid, Cerebro Spinal,Fluid, Cerebrospinal,Fluids, Cerebro Spinal,Fluids, Cerebrospinal,Spinal Fluid, Cerebro,Spinal Fluids, Cerebro
D003453 Cryptococcosis Fungal infection caused by genus CRYPTOCOCCUS. C gattii Infection,C neoformans Infection,C. gattii Infection,C. neoformans Infection,Cryptococcus Infection,Cryptococcus Infections,Cryptococcus gattii Infection,Torulosis,Cryptococcus neoformans Infection,C gattii Infections,C neoformans Infections,C. gattii Infections,C. neoformans Infections,Cryptococcoses,Cryptococcus gattii Infections,Cryptococcus neoformans Infections,Infection, C gattii,Infection, C neoformans,Infection, C. gattii,Infection, C. neoformans,Infection, Cryptococcus,Infection, Cryptococcus gattii,Infection, Cryptococcus neoformans,Infections, C gattii,Infections, C. neoformans,Toruloses
D003455 Cryptococcus neoformans A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella neoformans. Blastomyces neoformans,Debaryomyces neoformans,Filobasidiella neoformans,Lipomyces neoformans,Saccharomyces neoformans,Torula neoformans,Torulopsis neoformans,Cryptococcus neoformans var. grubii
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D012703 Serotyping Process of determining and distinguishing species of bacteria or viruses based on antigens they share. Serotypings
D013785 Thailand Formerly known as Siam, this is a Southeast Asian nation at the center of the Indochina peninsula. Bangkok is the capital city. Kingdom of Thailand,Siam
D017088 AIDS-Related Opportunistic Infections Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus. HIV-Related Opportunistic Infections,Opportunistic Infections, AIDS-Related,Opportunistic Infections, HIV-Related,AIDS Related Opportunistic Infections,AIDS-Related Opportunistic Infection,HIV Related Opportunistic Infections,HIV-Related Opportunistic Infection,Infection, HIV-Related Opportunistic,Infections, HIV-Related Opportunistic,Opportunistic Infection, AIDS-Related,Opportunistic Infection, HIV-Related,Opportunistic Infections, AIDS Related,Opportunistic Infections, HIV Related

Related Publications

N Poonwan, and Y Mikami, and S Poosuwan, and J Boon-Long, and N Mekha, and M Kusum, and K Yazawa, and R Tanaka, and K Nishimura, and K Konyama
[Serotyping of 27 Cryptococcus neoformans strains isolated in Venezuela].
January 1989, Acta cientifica venezolana,
N Poonwan, and Y Mikami, and S Poosuwan, and J Boon-Long, and N Mekha, and M Kusum, and K Yazawa, and R Tanaka, and K Nishimura, and K Konyama
In vitro susceptibility to antifungal agents of clinical and environmental Cryptococcus neoformans isolated in Southern of Brazil.
January 2001, Revista do Instituto de Medicina Tropical de Sao Paulo,
N Poonwan, and Y Mikami, and S Poosuwan, and J Boon-Long, and N Mekha, and M Kusum, and K Yazawa, and R Tanaka, and K Nishimura, and K Konyama
Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
March 2006, Antimicrobial agents and chemotherapy,
N Poonwan, and Y Mikami, and S Poosuwan, and J Boon-Long, and N Mekha, and M Kusum, and K Yazawa, and R Tanaka, and K Nishimura, and K Konyama
[Susceptibility to antifungal agents among Cryptococcus neoformans varieties isolated from patients at a university hospital].
January 2008, Revista da Sociedade Brasileira de Medicina Tropical,
N Poonwan, and Y Mikami, and S Poosuwan, and J Boon-Long, and N Mekha, and M Kusum, and K Yazawa, and R Tanaka, and K Nishimura, and K Konyama
In vitro susceptibility to 9 antifungal agents of 14 strains of Zygomycetes isolated from clinical specimens.
December 1994, Mycopathologia,
N Poonwan, and Y Mikami, and S Poosuwan, and J Boon-Long, and N Mekha, and M Kusum, and K Yazawa, and R Tanaka, and K Nishimura, and K Konyama
Prevalence and antifungal susceptibility of Cryptococcus neoformans isolated from pigeon excreta in Chon Buri Province, Eastern Thailand.
January 2013, Medical mycology journal,
N Poonwan, and Y Mikami, and S Poosuwan, and J Boon-Long, and N Mekha, and M Kusum, and K Yazawa, and R Tanaka, and K Nishimura, and K Konyama
Temperature affects the susceptibility of Cryptococcus neoformans biofilms to antifungal agents.
March 2010, Medical mycology,
N Poonwan, and Y Mikami, and S Poosuwan, and J Boon-Long, and N Mekha, and M Kusum, and K Yazawa, and R Tanaka, and K Nishimura, and K Konyama
Antifungal susceptibility profiles of Cryptococcus neoformans strains clinically isolated from non-HIV-infected patients in Nagasaki, Japan.
October 2023, Medical mycology,
N Poonwan, and Y Mikami, and S Poosuwan, and J Boon-Long, and N Mekha, and M Kusum, and K Yazawa, and R Tanaka, and K Nishimura, and K Konyama
In vitro antifungal susceptibilities and molecular typing of sequentially isolated clinical Cryptococcus neoformans strains from Croatia.
October 2011, Journal of medical microbiology,
N Poonwan, and Y Mikami, and S Poosuwan, and J Boon-Long, and N Mekha, and M Kusum, and K Yazawa, and R Tanaka, and K Nishimura, and K Konyama
Susceptibility to antifungal agents and genotypes of Brazilian clinical and environmental Cryptococcus gattii strains.
April 2012, Diagnostic microbiology and infectious disease,
Copied contents to your clipboard!